These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 23843154

  • 1. Log-linear human chorionic gonadotropin elimination in cases of retained placenta percreta.
    Stitely ML, Gerard Jackson M, Holls WH.
    Arch Gynecol Obstet; 2014 Feb; 289(2):259-62. PubMed ID: 23843154
    [Abstract] [Full Text] [Related]

  • 2. Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta.
    El-Bialy G, Kassab A, Armstrong M.
    Arch Gynecol Obstet; 2007 Oct; 276(4):371-3. PubMed ID: 17356825
    [Abstract] [Full Text] [Related]

  • 3. Partial placenta increta and methotrexate therapy: three case reports.
    Pinho S, Sarzedas S, Pedroso S, Santos A, Rebordão M, Avillez T, Casal E, Hermida M.
    Clin Exp Obstet Gynecol; 2008 Oct; 35(3):221-4. PubMed ID: 18754299
    [Abstract] [Full Text] [Related]

  • 4. Persistent retained placenta percreta: methotrexate treatment and Doppler flow characteristics.
    Nijman RG, Mantingh A, Aarnoudse JG.
    BJOG; 2002 May; 109(5):587-8. PubMed ID: 12066955
    [No Abstract] [Full Text] [Related]

  • 5. Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation.
    Zepiridis L, Zafrakas M, Theodoridis TD, Assimakopoulos E, Tzevelekis P, Athanatos D, Bontis JN, Tarlatzis BC.
    Arch Gynecol Obstet; 2009 Dec; 280(6):1041-4. PubMed ID: 19333613
    [Abstract] [Full Text] [Related]

  • 6. Placenta percreta: methotrexate treatment and MRI findings.
    Heiskanen N, Kröger J, Kainulainen S, Heinonen S.
    Am J Perinatol; 2008 Feb; 25(2):91-2. PubMed ID: 18176907
    [Abstract] [Full Text] [Related]

  • 7. Placenta increta: Use of dynamic MRI for diagnosis and evaluation of placental vascularity.
    Honnma H, Endo T, Hayashi T, Saito T.
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):131-3. PubMed ID: 16962230
    [No Abstract] [Full Text] [Related]

  • 8. Preservation of fertility and subsequent childbirth after methotrexate treatment of placenta percreta: a case report.
    Tamate M, Matsuura M, Habata S, Akashi Y, Tanaka R, Ishioka S, Endo T, Saito T.
    J Med Case Rep; 2015 Oct 19; 9():232. PubMed ID: 26480940
    [Abstract] [Full Text] [Related]

  • 9. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta.
    Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii S.
    J Obstet Gynaecol Res; 2000 Apr 19; 26(2):81-7. PubMed ID: 10870298
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A myotonic dystrophy 1 patient complicated with placental adherence after miscarriage of one dichorionic diamniotic twin following her tenth in vitro fertilization and embryo transfer.
    Endo T, Baba T, Sugio A, Morishita M, Takahashi M, Akashi Y, Ishioka S, Tachi N, Imai T, Tamakawa M, Saito T.
    Arch Gynecol Obstet; 2012 Dec 19; 286(6):1605-8. PubMed ID: 23011730
    [No Abstract] [Full Text] [Related]

  • 12. Persistent Human Chorionic Gonadotropin After Methotrexate Treatment and an Emergency Surgical Procedure for Ectopic Pregnancy.
    Kurt-Mangold M, Van Voorhis BJ, Krasowski MD.
    Lab Med; 2015 Dec 19; 46(3):254-8. PubMed ID: 26199268
    [Abstract] [Full Text] [Related]

  • 13. Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy.
    Natale A, Candiani M, Barbieri M, Calia C, Odorizzi MP, Busacca M.
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov 10; 117(1):87-92. PubMed ID: 15474251
    [Abstract] [Full Text] [Related]

  • 14. Ultrasonographic findings in conservatively treated placenta percreta.
    Wong HS, Parker S.
    Ultrasound Obstet Gynecol; 2005 Oct 10; 26(5):580-1. PubMed ID: 16184504
    [No Abstract] [Full Text] [Related]

  • 15. Biomarkers of abnormally invasive placenta.
    Al-Khan A, Youssef YH, Feldman KM, Illsley NP, Remache Y, Alvarez-Perez J, Mannion C, Alvarez M, Zamudio S.
    Placenta; 2020 Feb 10; 91():37-42. PubMed ID: 32174305
    [Abstract] [Full Text] [Related]

  • 16. Conservative endovascular management of retained placenta accreta with marked vascularity after abortion or delivery.
    Takeda A, Koike W.
    Arch Gynecol Obstet; 2017 Dec 10; 296(6):1189-1198. PubMed ID: 28980065
    [Abstract] [Full Text] [Related]

  • 17. Conservative management of placenta accreta in a multiparous woman.
    Hunt JC.
    J Pregnancy; 2010 Dec 10; 2010():329618. PubMed ID: 21490740
    [Abstract] [Full Text] [Related]

  • 18. Management of placenta accreta.
    Sentilhes L, Goffinet F, Kayem G.
    Acta Obstet Gynecol Scand; 2013 Oct 10; 92(10):1125-34. PubMed ID: 23869630
    [Abstract] [Full Text] [Related]

  • 19. Using methotrexate to treat placenta accreta.
    Cole MD.
    AWHONN Lifelines; 2002 Dec 10; 6(6):486-7. PubMed ID: 12593248
    [No Abstract] [Full Text] [Related]

  • 20. Management of Abnormal Placenta Implantation with Methotrexate: A Review of Published Data.
    Farasatinasab M, Moghaddas A, Dashti-Khadivaki S, Raoofi Z, Nasiripour S.
    Gynecol Obstet Invest; 2016 Dec 10; 81(6):481-496. PubMed ID: 27384687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.